BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5340971)

  • 1. Atromid and platelet adhesiveness in multiple sclerosis.
    Millac P; Caspary EA; Prineas J
    J Atheroscler Res; 1967; 7(3):397-400. PubMed ID: 5340971
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic activity of venous blood of patients with multiple sclerosis.
    Menon IS; Dewar HA; Newell DJ
    Neurology; 1969 Jan; 19(1):101-4. PubMed ID: 4886662
    [No Abstract]   [Full Text] [Related]  

  • 3. A three-year trial of atromid therapy in exudative diabetic retinopathy.
    Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
    Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H
    Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
    Engström J
    Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atromid].
    Borchgrevink CF
    Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
    [No Abstract]   [Full Text] [Related]  

  • 7. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial of "Atheran" and "Atromid-S" in atherosclerosis.
    Barnett AJ; Carson V
    Med J Aust; 1966 Jun; 1(23):965-70. PubMed ID: 5939995
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF; Ireland JT; Oliver MF
    Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of platelet stickiness tests during an atromid-S trial.
    O'Brien JR; Heywood JB
    Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
    [No Abstract]   [Full Text] [Related]  

  • 12. Communications. Action of Atromid-S (clofibrate) on intra-ocular pressure.
    Gloster J; Hartley RE; Perkins ES
    Br J Ophthalmol; 1968 Nov; 52(11):793-800. PubMed ID: 4972749
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet stickiness in multiple sclerosis.
    Caspary EA; Prineas J; Miller H; Field EJ
    Lancet; 1965 Nov; 2(7422):1108-9. PubMed ID: 4158809
    [No Abstract]   [Full Text] [Related]  

  • 14. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory indices in clofibrate therapy of juvenile-onset diabetes.
    Narduzzi JV; Danowski TS; Weir TF; Alley RA; Vester JW; Moses C
    Clin Pharmacol Ther; 1967; 8(6):817-23. PubMed ID: 4862480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.
    Carson P; McDonald L; Pickard S; Pilkington T; Davies B; Love F
    Br Heart J; 1966 May; 28(3):400-3. PubMed ID: 5936972
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.